| abstract |
The present invention overcomes the problem that only single or several kinase gene mutation points can be predicted in current clinical application and cannot meet actual clinical detection and diagnosis requirements, and provides a colorectal cancer multigene screening probe, as well as a method and reagent for colorectal cancer gene screening In order to efficiently detect gene mutations, accurately type colorectal cancer patients, and reduce the cost of genetic testing for patients. |